SpringWorks Therapeutics Inc [NASDAQ: SWTX] loss -0.22% or -0.1 points to close at $46.21 with a heavy trading volume of 5970853 shares.
The daily chart for SWTX points out that the company has recorded 26.78% gains over the past six months.
If we look at the average trading volume of 4.70M shares, SWTX reached to a volume of 5970853 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about SpringWorks Therapeutics Inc [SWTX]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for SWTX shares is $47.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on SWTX stock is a recommendation set at 3.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Evercore ISI have made an estimate for SpringWorks Therapeutics Inc shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on November 20, 2024. While these analysts kept the previous recommendation, Guggenheim raised their target price to Buy. The new note on the price target was released on February 05, 2024, representing the official price target for SpringWorks Therapeutics Inc stock. Previously, the target price had yet another raise to $45, while BofA Securities analysts kept a Buy rating on SWTX stock. On January 19, 2021, analysts increased their price target for SWTX shares from 87 to 101.
The Average True Range (ATR) for SpringWorks Therapeutics Inc is set at 0.90, with the Price to Sales ratio for SWTX stock in the period of the last 12 months amounting to 15.84. The Price to Book ratio for the last quarter was 8.30, with the Price to Cash per share for the same quarter was set at 3.82.
Trading performance analysis for SWTX stock
SpringWorks Therapeutics Inc [SWTX] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -0.02. With this latest performance, SWTX shares gained by 14.10% in over the last four-week period, additionally plugging by 26.78% over the last 6 months – not to mention a rise of 3.06% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for SWTX stock in for the last two-week period is set at 58.07, with the RSI for the last a single of trading hit 64.01, and the three-weeks RSI is set at 54.51 for SpringWorks Therapeutics Inc [SWTX]. The present Moving Average for the last 50 days of trading for this stock 44.51, while it was recorded at 46.20 for the last single week of trading, and 40.11 for the last 200 days.
SpringWorks Therapeutics Inc [SWTX]: A deeper dive into fundamental analysis
SpringWorks Therapeutics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 4.18 and a Current Ratio set at 4.33.
An analysis of Institutional ownership at SpringWorks Therapeutics Inc [SWTX]
The top three institutional holders of SWTX stocks are: FMR LLC with ownership of 11.11 million shares, which is approximately 14.9922%. VANGUARD GROUP INC, holding 6.54 million shares of the stock with an approximate value of $$246.53 million in SWTX stocks shares; and VANGUARD GROUP INC, currently with $$211.68 million in SWTX stock with ownership which is approximately 7.5812%.
